IVERIC bio (ISEE) Misses Q4 EPS by 10c

IVERIC bio (NASDAQ: ISEE) reported Q4 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Movano (MOVE) Misses Q2 EPS by 195c